Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 4/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | NSD2 | O96028 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27845557 | 0.85 | ELANE (0.42) | ELANEMAOBALDH1A1ATML3MBTL1 | |
| SCHEMBL10187806 | 0.80 | ELANE (0.44) | ELANEMAOBALDH1A1ATML3MBTL1 | |
| SCHEMBL5054006 | 0.80 | ELANE (0.44) | ELANEMAOBALDH1A1ATML3MBTL1 | |
| SCHEMBL31257827 | 0.80 | ELANE (0.44) | ELANEMAOBALDH1A1ATML3MBTL1 | |
| SCHEMBL1255890 | 0.79 | ELANE (0.47) | ELANEMAOBALDH1A1ATML3MBTL1 | |
| SCHEMBL24142221 | 0.78 | ALDH1A1 (0.46) | ELANEMAOBALDH1A1ATML3MBTL1 | |
| SCHEMBL11924477 | 0.78 | ELANE (0.43) | ELANEMAOBALDH1A1ATML3MBTL1 | |
| SCHEMBL10946374 | 0.78 | ELANE (0.46) | ELANEMAOBALDH1A1ATML3MBTL1 | |
| SCHEMBL544447 | 0.78 | MAOB (0.49) | ELANEMAOBALDH1A1ATML3MBTL1 | |
| SCHEMBL8587544 | 0.77 | ELANE (0.42) | ELANEMAOBALDH1A1ATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119301526-A | Composition for forming resist underlayer film | 日产化学株式会社 | 2025-01-10 | — | — | CN | disclosed |
| CN-114868076-A | Radical generating film forming composition, radical generating film, and method for producing horizontal electric field liquid crystal cell | 日产化学株式会社 | 2022-08-05 | — | — | CN | disclosed |
| CN-114846397-A | Method for manufacturing patterned liquid crystal display element | 日产化学株式会社 | 2022-08-02 | — | — | CN | disclosed |
| CN-109153852-B | Composition for forming release layer and release layer | 日产化学株式会社 | 2022-07-05 | — | — | CN | disclosed |
| CN-109476913-B | Composition for forming release layer | 日产化学株式会社 | 2022-03-01 | — | — | CN | disclosed |
| US-6638631-B2 | Stress relieving films comprising crosslinked mixtures of polysiloxanes, polyimides, polyamideimides copolymers and/or polyamides used as interfaces for semiconductors or printed circuits | HITACHI, LTD. (JP) | 2003-10-28 | — | — | US | disclosed |
| US-6638352-B2 | For use in printed circuit boards; semiconductors | HITACHI, LTD. (JP) | 2003-10-28 | — | — | US | disclosed |
| US-20030047351-A1 | Stress relieving films comprising crosslinked mixtures of polysiloxanes, polyimides, polyamideimides copolymers and/or polyamides used as interfaces for semiconductors or printed circuits | SATSU YUICHI (JP) | 2003-03-13 | — | — | US | disclosed |
| US-20030049193-A1 | For use in printed circuit boards; semiconductors | HITACHI,L TD (JP) | 2003-03-13 | — | — | US | disclosed |
| US-3933713-A | Method for preparing aromatic polyesters | SOKOLOV LEV BORISOVICH | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030049193-A1 | For use in printed circuit boards; semiconductors | ASIC1, ASIC3, RIOK2 | ELANE 1230/4885MAOB 4512/4885ALDH1A1 4510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.